Objectives: Previous studies have suggested an association between nonwhite race and poor outcomes in small subsets of cardiac surgery patients who require extracorporeal life support. This study aims to examine the association of race/ethnicity with mortality in pediatric patients who receive extracorporeal life support for cardiac support. Design: Retrospective analysis of registry data. Setting: Prospectively collected multi-institutional registry data. Subjects: Data from all North American pediatric patients in the Extracorporeal Life Support International Registry who received extracorporeal life support for cardiac support between 1998 and 2012 were analyzed. Multivariate regression models were constructed to examine the association between race/ethnicity and hospital mortality, adjusting for demographics, diagnosis, preextracorporeal life support care, extracorporeal life support variables, and extracorporeal life support-related complications. Interventions: None. Measurements and Main Results: Of 7,106 patients undergoing cardiac extracorporeal life support, the majority of patients were of white race (56.9%) with black race (16.7%), Hispanic ethnicity (15.8%), and Asian race (2.8%) comprising the other major race/ ethnic groups. The mortality rate was 53.9% (n = 3,831). After adjusting for covariates, multivariate analysis identified black race (relative risk = 1.10; 95% CI, 1.04-1.16) and Hispanic ethnicity (relative risk = 1.08; 95% CI, 1.02-1.14) as independent risk factors for mortality. Conclusions: Black race and Hispanic ethnicity are independently associated with mortality in children who require cardiac extracorporeal life support. (Crit Care Med 2017; 45:670-678) 
xtracorporeal life support (ECLS) is a lifesaving and highly specialized therapy used for cardiac, respiratory, and extracorporeal resuscitative support. Variable access to highly specialized therapies such as ECLS may result in racial and ethnic disparities in ECLS-related clinical outcomes. The impact of race on survival has been previously characterized in several forms of advanced therapy, including cardiac surgery, in which nonwhite patients have increased odds of mortality (1) (2) (3) (4) (5) (6) . Nonwhite race/ethnicity has also been identified as a risk factor in limited subsets of cardiac ECLS, patients who received extracorporeal cardiopulmonary resuscitation (ECPR), and in reports that dichotomously categorize race/ethnicity as white versus nonwhite (7) (8) (9) (10) . However, a comprehensive evaluation of the overall impact of race/ethnicity in ECLS patients who require cardiac support has not been previously performed. In this study, we investigate the association of race/ethnicity with mortality in children undergoing ECLS for cardiac support using data from the Extracorporeal Life Support Organization (ELSO) international registry (11) . In addition, we examine factors that potentially contribute to race/ethnicity-related variability in clinical outcomes in these patients.
MATERIALS AND METHODS
The ELSO international registry is the largest database of prospectively collected, de-identified clinical ECLS data, containing data from over 50,000 ECLS patients from over 200 international centers (12) . The Institutional Review Board at the University of Washington exempted this study from human subjects research guidelines. The ELSO registry categorizes indication for ECLS as cardiac, respiratory, or ECPR.
All North American pediatric patients (< 19 yr) who received ECLS for a cardiac indication between 1998 and 2012 were included. Data analyses were limited to the index cardiac ECLS exposure for patients who experienced multiple periods of ECLS. The independent variable of race/ethnicity was categorized as white race, black race, Hispanic ethnicity, Asian race, or other race/ethnicity. The primary dependent variable of interest was hospital mortality, defined as death prior to hospital discharge. We also explored the timing of death in patients supported with ECLS. Secondary outcomes included mortality during the initial ECLS exposure (death during ECLS) and surviving the initial ECLS exposure but dying prior to hospital discharge, including dying during subsequent ECLS exposures (death after ECLS). ELSO records outcomes of each ECLS run, including recovery from ECLS, and death due to: catastrophic hemorrhage, diagnosis incompatible with life, irreversible organ failure, or withdrawal of ECLS.
Patients were divided into three age categories: neonates (< 29 d), infants (29-365 d), and children (1-18 yr Univariate analysis of baseline demographics, pre-ECLS factors, and ECLS variables across race/ethnicity groups and hospital survival was performed. The chi-square test or Fisher-FreemanHalton test was performed for dichotomous or categorical data. Ordinal and continuous data were analyzed by Wilcoxon signed rank or Kruskal-Wallis tests and t tests or analysis of variance (ANOVA) tests, respectively. Statistical significance was defined as p value of less than 0.05. Variables determined to be significantly different by univariate analysis were included in multivariate models. Given that death was a frequent outcome in this cohort, multivariate modified Poisson regression models estimating the relative risk (RR) were created to examine the association between race/ethnicity and hospital mortality. Initial baseline models included only race/ethnicity as the predictor variable. Subsequent regression models sequentially added age group and ECLS era, diagnostic category, pre-ECLS mechanical ventilation time, pre-ECLS medications, ECLS factors (cannulation site, ECLS mode, and ECLS duration), and ECLS complications. An additional regression model was constructed to examine the association between race/ethnicity and death during ECLS, using the same covariates as the hospital mortality model. Interactions between race/ethnicity and other covariates were evaluated in the hospital mortality model. STATA 12.1 (StataCorp LP, College Station, TX) was used for the analysis.
RESULTS

Univariate Analyses
Data from 7,106 patients meeting inclusion criteria were included in the analysis. The largest proportion of patients were of white race (56.9%), with black race (16.7%), Hispanic ethnicity (15.8%), and Asian race (2.8%) comprising the other major racial/ethnic groups. Baseline characteristics, ECLS variables, and outcomes by race/ethnicity groups are reported in Tables  1 and 2 . When compared with white race, nonwhite race/ethnicity groups had a higher proportion of infants and children, patients with myocarditis/cardiomyopathy, ECLS during later eras, lower rates of chest cannulation, and a lower pre-ECLS pH (p < 0.05 for all comparisons). Race/ethnicity was not associated with duration of mechanical ventilation before ECLS.
Nonwhite race/ethnicity was associated with increased risk of ECLS neurologic complications (21.8% vs 18.5%; p < 0.01) ( Table 2) . Additionally, nonwhite race/ethnicity was associated with increased hospital mortality (55.9% vs 52.5%; p = 0.005). Nonwhite patients were also at increased risk of death during ECLS (33.8% vs 29.4%; p < 0.01) but not death after ECLS (21.7% vs 22.7%; p = 0.65). There was a significant variation in ECLS run outcomes across race/ethnic groups (p < 0.01). Nonwhite patients had a lower rate of recovery during ECLS (66.2% vs 70.4%) and lower rate of withdrawal of ECLS (4.6% vs 5.7%) when compared with white patients. Nonwhite patients had higher rates of catastrophic hemorrhage (3.4% vs 2.4%), diagnoses incompatible with life (4.9% vs 4.3%), and irreversible organ failure (20.3% vs 16.9%) than white patients.
The hospital mortality rate was 53.9% (n = 3,831) and varied significantly across most baseline characteristics ( Table 3) . Neonatal age category, STAT 5 procedures, early ECLS era, chest cannulation, increased duration of pre-ECLS mechanical ventilation, lower blood pH, increased duration of ECLS, and multiple complications were more common in nonsurvivors. These risk factors generally remained associated with hospital mortality when hospital mortality was examined by race/ethnicity (Supplemental Table 1 , Supplemental Digital Content 1, http://links.lww.com/ CCM/C287). Among white, black and Hispanic patients, neonatal age group, earlier ECLS era, increased duration of ECLS, and multiple complications were associated with increased mortality. Interestingly, the survival rate for black patients undergoing STAT 5 procedures (25%) was significantly lower than white (41%) and Hispanic patients (41%). The distribution of risk factors for mortality varied across age groups (Supplemental Table 2 procedures, longer duration of pre-ECLS mechanical ventilation, chest cannulation, hospital mortality, death during ECLS, and death after ECLS being more common among neonates.
Multivariate Analyses
In all additive iterations of the hospital mortality model, black race (RR range, 1.07-1.13) and Hispanic ethnicity (RR range, 1.08-1.12) (Fig. 1) were associated with increased mortality. After adjusting for all covariates (ECMO complications in Fig. 1 ), black race (RR = 1.10; 95% CI, 1.04-1.16) and Hispanic ethnicity (RR = 1.08; 95% CI, 1.02-1.14) were associated with increased hospital mortality when compared with white patients. Additionally, black and Hispanic patients were also at increased risk of death during ECLS (black: RR = 1.12; 95% CI, 1.02-1.23 and Hispanic: RR = 1.11; 95% CI, 1.01-1.21) in the fully adjusted model. While the point estimate of black race and Hispanic ethnicity changed with additional covariates, none of the covariates altered the point estimate of race/ethnicity for black or Hispanic patients by more than 10%. Pre-ECLS blood pH was not included in the final model due to missing data (18) 192 (17) 25 (13) 52 (13) 17 (12) Unknown cardiac procedure 114 (3) 29 (2) 28 (2) 5 (3) 6 (1) 15 (10) Myocarditis and cardiomyopathy 317 (8) 177 (15) 112 (10) 30 (15) 52 (13) 8 (6) Structural heart disease, no procedure 377 (9) 123 (10) 100 (9) 11 (5) 38 (9) 14 (10) Other cardiac disease 315 (8) 104 (9) 89 (8) 11 (5) 28 (7) 13 (9) No cardiac disease (Fig. 2) . 
DISCUSSION
In this analysis of pediatric patients who received cardiac ECLS, black race, and Hispanic ethnicity were identified as independent risk factors for hospital mortality. Variability in medical care before, during, and after ECLS may have contributed to observed race/ethnicity-related differences in survival. Nevertheless, black and Hispanic patients continue to experience increased risk of death after adjusting for these covariates. Although nonwhite race previously has been identified as a risk factor for hospital mortality in limited subgroups of cardiac and respiratory ECLS patients (7) (8) (9) (10) (14) (15) (16) , an association between individual race/ethnicity and clinical outcomes has not been previously established in a large, unrestricted cohort of cardiac ECLS patients. The reason for racial and ethnic disparities in ECLS survival is unknown but is likely to be multifactorial in nature. Disparate access to pre-ECLS care, differences in pre-ECLS clinical status, variability in ECLS and post-ECLS management, cultural preferences, and socioeconomic factors may individually or collectively impact ECLS survival and risk for ECLS complications. Race and ethnicity-based differences in access to care are well established in several non-ECLS patient populations. Previous studies have reported that nonwhite adults are less likely to receive timely and appropriate care for acute myocardial infarction (2, 4, 17, 18) and critically ill Hispanic children have higher severity of illness than their white counterparts (19) . In the current study, black and Hispanic patients did not have significantly longer periods of pre-ECLS mechanical ventilation, a previously demonstrated risk factor for poor survival (14) . Additionally, while there was a statistically significant difference in blood pH across race/ethnicity groups, the clinical difference was small. Finally, the addition of pre-ECLS care into regression model did not substantively alter the association of race/ethnicity and mortality. These findings suggest that although there may be slight differences in pre-ECLS care, they are unlikely to be the driving force in ECLS survival disparities.
Variations in care during ECLS may contribute to racial/ ethnic disparities in hospital survival. Complications during ECLS are commonly associated with increased mortality (7, 10, 15) , and previous studies have demonstrated race/ethnicity-based differences in complication rates in congenital heart surgery patients (6) . We demonstrated that nonwhite patients were at increased risk of experiencing a neurologic ECLS complication. However, the addition of ECLS complications into the regression model, while attenuating the association between race/ ethnicity and mortality, did not significantly alter the association. Thus, although complications may be one mechanism for the black and Hispanic patients to experience ECLS disparities, it is not the only or main mechanism that may be driving this disparity.
Social factors, such as implicit racial biases and cultural preferences, may also be a contributing factor in worse outcomes observed in some groups. Implicit racial bias among healthcare professionals has been associated with variations in therapeutic decision-making (20, 21) and may influence provider decisions in initiating ECLS, treating complications, and post-ECLS care. These cumulative variations in decisionmaking may ultimately impact overall hospital survival for black and Hispanic patients. Furthermore, cultural preferences among patient families may also impact ECLS outcomes. Previous adult studies have suggested that nonwhite patients and families may be more likely to use highly invasive therapies (22, 23) . In our study, black and Asian patients had lower rates of withdrawal of ECLS and higher rates of death during ECLS due to other reasons such as hemorrhage, irreversible organ failure, and diagnoses that were incompatible with life. While these represent mutually exclusive outcome categories in the ELSO registry, the distinction may be less clear in many clinical situations. Nevertheless, racial and ethnic differences in cause of death during ECLS may reflect the impact of varying cultural preferences related to end-of-life decision-making. We found an interaction between black race and STAT category 5 procedures, the highest risk category for congenital heart surgery, suggesting that these patients are at increased risk of disparities in hospital mortality. Increased risk of mortality for black patients undergoing high-risk congenital heart surgery appears to be the main driver of overall disparities for black children. High-risk procedures are associated with increased risk of ECLS usage, mortality with and without ECLS support, and experiencing a complication (24, 25) . In this population, delays in access to care, variations in care delivery, and implicit bias may have a profound impact on outcomes. A similar pattern of increased risk in high-risk surgical procedures was not seen for Hispanic patients. This suggests that Hispanic patients may remain at increased risk of mortality regardless of the reasons for requiring ECLS.
Previous studies of congenital heart surgery patients have demonstrated that nonwhite patients are at increased risk of experiencing a complication, failure-to-rescue, and hospital mortality (5, 6, 26) . The findings of this study provide further understanding of the previously documented disparities. This study demonstrates one mechanism, increased ECLSassociated mortality, by which nonwhite patients experience postsurgical survival disparities. It is possible that common factors (delays in care, complications, and implicit bias) contribute to both increased surgical mortality and ECLS mortality. However, after adjustment for these variables (with the exception of implicit bias), black and Hispanic patients continued to experience increased risk of hospital mortality, suggesting that this is not the only mechanism for ECLS disparities. Furthermore, it should be noted that ECLSassociated mortality accounts for less than one third of all perioperative deaths in congenital heart surgery (25) . As such, although ECLS-associated disparities may contribute to postsurgical survival disparities, it is unlikely that these disparities are the sole etiology for racial/ethnic differences in cardiac surgical mortality.
This analysis is subject to several important limitations inherent to all retrospective studies. ELSO registry data are collected from greater than 100 de-identified ECLS centers and information related to center geography, clinical resources, cardiac care volume, and local patient population is unknown. It is not possible to examine within-hospital and interhospital models of disparity. Additionally, many registry data fields are structured as mutually exclusive categories (e.g., mechanism of death during ECLS) and, therefore, may not reflect the complexity and intricacies of medical decision-making related to ECLS. Finally, while we adjusted for many variables that might influence the association of race/ethnicity with mortality, there may be other important confounders that were not measured or known that might explain our findings.
CONCLUSIONS
Black and Hispanic pediatric patients who require ECLS for cardiac indications are at increased risk of dying when compared with white patients. It is unknown whether race/ethnicity-based differences in ECLS survival reflect disparities in access to care, differences in socioeconomic status, or regional variability in ECLS care. Future studies to explore the impact of these factors on race/ethnicity-related differences in ECLS survival are warranted.
